Matthew Feinstein, a Third Coast CFAR Pilot Awardee, will speak at the “HIV and CVD: Reducing Cardiovascular Risk in Patients with HIV/AIDS” event on March 17. With Priscilla Hsue, MD, FACC, they will address the specific need of cardiovascular practitioners, family practice physicians and infectious disease specialists to understand the importance of the intersection between cardiovascular disease (CVD) and HIV infection, the impact of antiretroviral therapy (ART) on cardiovascular (CV) risk, and the ability to implement recommended risk-reduction approaches to reduce the patients’ risk of CVD.
- Post-Doctoral Position in biomedical informatics and HIV research at University of Texas Health Science Center at Houston
- Harold Pollack, PhD Pens Op-Ed in NY Times
- Open for Applications: Training Institute for Dissemination and Implementation Research
- Thomas Hope, Director of Viral Pathogenesis Core, in Nature Medicine
- Inger E. Burnett-Zeigler, Third Coast CFAR Member, featured in the New York Times
- Robert L. Murphy Named Elite Medical and Biological Engineering Fellow